Shenzhen, China

Yingxin Lu

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Longuide Biopharma Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yingxin Lu. Retrieved from https://idiyas.com/inventor/yingxin-lu-30ogbzpf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Lipid Nanoparticle Formulations by Yingxin Lu

Introduction

Yingxin Lu is an accomplished inventor based in Shenzhen, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of lipid nanoparticle formulations. His work focuses on innovative methods for delivering nucleic acids, such as mRNA, which are crucial for various therapeutic applications.

Latest Patents

Yingxin Lu holds a patent for "Lipids and lipid nanoparticle formulations." This patent relates to lipids and lipid nanoparticle formulations, as well as methods for using these formulations to deliver nucleic acids. His innovative approach has the potential to enhance the efficacy of mRNA delivery systems.

Career Highlights

Yingxin Lu is currently employed at Longuide Biopharma Corporation, where he continues to advance research in lipid formulations. His expertise in this area has positioned him as a key figure in the biopharmaceutical industry. With a total of 1 patent, he is recognized for his contributions to the field.

Collaborations

Yingxin Lu collaborates with notable colleagues, including Longgui Zhang and Yuebao Zhang. These partnerships enhance the research and development efforts at Longuide Biopharma Corporation, fostering innovation in lipid-based therapies.

Conclusion

Yingxin Lu's work in lipid nanoparticle formulations represents a significant advancement in the delivery of nucleic acids. His contributions to the field are paving the way for future innovations in biopharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…